BOSTON, March 5, 2019 /PRNewswire/ -- HydroCision, a pioneer in the use of high velocity water jet technology for the minimally invasive treatment of musculoskeletal, spine and wound care conditions, today announced the appointment of Alain Tranchemontagne as Chief Executive Officer (CEO).
"We are delighted to have Alain spearhead the next growth chapter in HydroCision's future," said John Schulte, HydroCision's newly appointed Chairman of the Board. "The Board was impressed with Alain's proven track record at major medical device companies, his leadership and market development experience, as well as his passion and energy to broaden the use of our patented, proprietary technology."
Tranchemontagne is a distinguished, seasoned medical device executive, bringing extensive commercial and P&L experience to his role at HydroCision. He spent the previous eleven years at Smith & Nephew, most recently serving as Senior Vice President (SVP), Commercial Development for their U.S. business. During his tenure at Smith & Nephew he also served in other core leadership roles, including SVP, Commercial Services for the Advanced Surgical Devices Division, SVP, Marketing, Endoscopy Division and SVP & GM, Capital Business. Prior to that, he spent five years at Covidien (Medtronic) in various senior marketing roles in the Patient Care Division.
"I'm incredibly honored to be joining HydroCision, and I look forward to working closely with the dedicated HydroCision employees and the Board to deliver on the enormous opportunity that lies ahead," commented Tranchemontagne. "I'm also eager to quickly accelerate HydroCision's growth trajectory, particularly leveraging our unique and differentiated technology into new surgical applications."
About HydroCision
HydroCision, Inc is a privately held medical device company focused on the development and commercialization of proprietary fluid-jet technology. The company has established a unique patent estate covering the use of high velocity water jets for precisely removing soft tissue without generating heat. Current commercial applications include the fields of wound care, spine surgery, interventional pain and orthopedic sports medicine.
For more information on HydroCision,Inc, please visit www.HydroCision.com.
For more information:Helen GillisManager, Customer Care(978) 289-1352
Advertisement
"We are delighted to have Alain spearhead the next growth chapter in HydroCision's future," said John Schulte, HydroCision's newly appointed Chairman of the Board. "The Board was impressed with Alain's proven track record at major medical device companies, his leadership and market development experience, as well as his passion and energy to broaden the use of our patented, proprietary technology."
Advertisement
Tranchemontagne is a distinguished, seasoned medical device executive, bringing extensive commercial and P&L experience to his role at HydroCision. He spent the previous eleven years at Smith & Nephew, most recently serving as Senior Vice President (SVP), Commercial Development for their U.S. business. During his tenure at Smith & Nephew he also served in other core leadership roles, including SVP, Commercial Services for the Advanced Surgical Devices Division, SVP, Marketing, Endoscopy Division and SVP & GM, Capital Business. Prior to that, he spent five years at Covidien (Medtronic) in various senior marketing roles in the Patient Care Division.
"I'm incredibly honored to be joining HydroCision, and I look forward to working closely with the dedicated HydroCision employees and the Board to deliver on the enormous opportunity that lies ahead," commented Tranchemontagne. "I'm also eager to quickly accelerate HydroCision's growth trajectory, particularly leveraging our unique and differentiated technology into new surgical applications."
About HydroCision
HydroCision, Inc is a privately held medical device company focused on the development and commercialization of proprietary fluid-jet technology. The company has established a unique patent estate covering the use of high velocity water jets for precisely removing soft tissue without generating heat. Current commercial applications include the fields of wound care, spine surgery, interventional pain and orthopedic sports medicine.
For more information on HydroCision,Inc, please visit www.HydroCision.com.
For more information:Helen GillisManager, Customer Care(978) 289-1352
View original content:http://www.prnewswire.com/news-releases/hydrocision-appoints-medical-device-executive-with-global-commercial-and-market-development-experience-as-new-ceo-300806997.html
SOURCE HydroCision, Inc.
